Present and future of influenza prevention in pediatrics

The virosomal adjuvanted influenza vaccine

(2010) Selma Calcagnile et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

MF59-adjuvanted vaccine: a safe and useful tool to enhance and broaden protection against seasonal influenza viruses in subjects at risk

(2010) Paolo Durando et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Clinical studies assessing immunogenicity and safety of intradermally administered influenza vaccines

(2010) Vanessa Vankerckhoven et al.   Expert Opinion on Drug Delivery

Oseltamivir-induced resistant pandemic A/H1N1 influenza virus in a child with cystic fibrosis and Pseudomonas aeruginosa infection

(2010) Susanna Esposito et al.   JOURNAL OF CLINICAL VIROLOGY

Effectiveness of inactivated influenza vaccine in children aged 9 months to 3 years: an observational cohort study

(2010) Santtu Heinonen et al.   LANCET INFECTIOUS DISEASES

Dissolving polymer microneedle patches for influenza vaccination

(2010) Sean P Sullivan et al.   NATURE MEDICINE

Immunogenicity and Safety of MF59-Adjuvanted H5N1 Influenza Vaccine From Infancy to Adolescence

(2010) T. Vesikari et al.   PEDIATRICS

Changes in Human Langerhans Cells Following Intradermal Injection of Influenza Virus-Like Particle Vaccines

(2010) Marc Pearton et al.   PLoS One

Genetic sequence analysis of influenza viruses and illness severity in ill children previously vaccinated with live attenuated or inactivated influenza vaccine

(2010) Chin-Fen Yang et al.   VACCINE

New emerging technologies and the intradermal route: the novel way to immunize against influenza

(2010) Ann R. Falsey   VACCINE

A randomized clinical trial assessing immunogenicity and safety of a double dose of virosomal-adjuvanted influenza vaccine administered to unprimed children aged 6–35 months

(2010) Susanna Esposito et al.   VACCINE

Comparison of egg and high yielding MDCK cell-derived live attenuated influenza virus for commercial production of trivalent influenza vaccine: In vitro cell susceptibility and influenza virus replication kinetics in permissive and semi-permissive cells

(2010) Althaf I. Hussain et al.   VACCINE

Safety of MF59-adjuvanted versus non-adjuvanted influenza vaccines in children and adolescents: An integrated analysis

(2010) Steven Black et al.   VACCINE

Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin

(2010) Larry R. Smith et al.   VACCINE

Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6–35 months

(2010) Alfonso Carmona et al.   VACCINE

Clinical importance and impact on the households of oseltamivir-resistant seasonal A/H1N1 influenza virus in healthy children in Italy

(2010) Susanna Esposito et al.   Virology Journal

Antivirals for Influenza

(2010) Steven M. Smith et al.   PEDIATRIC DRUGS

The Burden of Influenza in Children: Time for Prevention

(2009) Kathryn M. Edwards   CLINICAL INFECTIOUS DISEASES

Virologically Confirmed Population‐Based Burden of Hospitalization Caused by Influenza A and B among Children in Hong Kong

(2009) Susan S. Chiu et al.   CLINICAL INFECTIOUS DISEASES

The rational use of influenza vaccines in healthy children and children with underlying conditions

(2009) Susanna Esposito et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Vaccination, squalene and anti-squalene antibodies: Facts or fiction?

(2009) Giuseppe Lippi et al.   European Journal of Internal Medicine

Continuous cell lines as a production system for influenza vaccines

(2009) Yvonne Genzel et al.   Expert Review of Vaccines

Humoral and Cellular Response to Influenza Vaccine in HIV-Infected Children With Full Viroimmunologic Response to Antiretroviral Therapy

(2009) Alessandra Viganò et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Enhanced Memory Responses to Seasonal H1N1 Influenza Vaccination of the Skin with the Use of Vaccine‐Coated Microneedles

(2009) Yeu‐Chun Kim et al.   JOURNAL OF INFECTIOUS DISEASES

Benefits of increasing the dose of influenza vaccine in residents of long-term care facilities: A randomized placebo-controlled trial

(2009) Herman J.M. Cools et al.   JOURNAL OF MEDICAL VIROLOGY

Efficacy of Injectable Trivalent Virosomal-Adjuvanted Inactivated Influenza Vaccine in Preventing Acute Otitis Media in Children With Recurrent Complicated or Noncomplicated Acute Otitis Media

(2009) Paola Marchisio et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Enhanced Immunogenicity of Seasonal Influenza Vaccines in Young Children Using MF59 Adjuvant

(2009) Timo Vesikari et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Immunogenicity and safety of intradermal versus intramuscular route of influenza immunization in infants less than 6 months of age: A randomized controlled trial

(2009) Susan S. Chiu et al.   VACCINE

Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus

(2009) Gian Vincenzo Zuccotti et al.   VACCINE

Efficacy and safety of a live attenuated influenza vaccine in adults 60 years of age and older

(2009) Pierre J.T. De Villiers et al.   VACCINE

Comparison of the trivalent live attenuated vs. inactivated influenza vaccines among U.S. military service members

(2009) Angelia A. Eick et al.   VACCINE

Adjuvanted seasonal influenza vaccines and perpetual viral metamorphosis: The importance of cross-protection

(2009) Filippo Ansaldi et al.   VACCINE

MF59®-adjuvanted influenza vaccine (FLUAD®) in children: Safety and immunogenicity following a second year seasonal vaccination

(2009) T. Vesikari et al.   VACCINE

Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults

(2009) Tino F. Schwarz et al.   VACCINE

Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: Preliminary report of an observer-blind, randomised trial

(2009) François Roman et al.   VACCINE

Improving seasonal and pandemic influenza vaccines

(2008) Melanie Saville et al.   Influenza and Other Respiratory Viruses

Effects of Adjuvants on the Safety and Immunogenicity of an Avian Influenza H5N1 Vaccine in Adults

(2008) David I. Bernstein et al.   JOURNAL OF INFECTIOUS DISEASES

Monoclonal Antibodies against the Fusion Peptide of Hemagglutinin Protect Mice from Lethal Influenza A Virus H5N1 Infection

(2008) N. Prabhu et al.   JOURNAL OF VIROLOGY

Effectiveness of Maternal Influenza Immunization in Mothers and Infants

(2008) K. Zaman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Tolerability of Cold-Adapted Influenza Vaccine, Trivalent, in Infants Younger Than 6 Months of Age

(2008) T. Vesikari et al.   PEDIATRICS

Safe administration of an inactivated virosomal adjuvanted influenza vaccine in asthmatic children with egg allergy

(2008) Susanna Esposito et al.   VACCINE

Influenza vaccine dosages

(2008) A.M. Palache et al.   VACCINE

Improved antibody responses in infants less than 1 year old using intradermal influenza vaccination

(2008) Tetsu Sugimura et al.   VACCINE

Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials

(2008) Janelle Rhorer et al.   VACCINE